Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.

Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM; ESSENCE and TIMI 11B Investigators.

Am Heart J. 2003 Jul;146(1):33-41.

PMID:
12851605
[PubMed - indexed for MEDLINE]
2.

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.

Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM.

JAMA. 2004 Jul 7;292(1):89-96. Review.

PMID:
15238596
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.

Murphy SA, Gibson CM, Morrow DA, Van de Werf F, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E.

Eur Heart J. 2007 Sep;28(17):2077-86. Epub 2007 Jun 28. Review.

PMID:
17600038
[PubMed - indexed for MEDLINE]
Free Article
5.

Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B.

Fox KA.

Semin Hematol. 2001 Apr;38(2 Suppl 5):67-74. Review.

PMID:
11449345
[PubMed - indexed for MEDLINE]
6.

Enoxaparin: an update of its clinical use in the management of acute coronary syndromes.

Ibbotson T, Goa KL.

Drugs. 2002;62(9):1407-30. Review.

PMID:
12076195
[PubMed - indexed for MEDLINE]
7.

Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.

French JK, Edmond JJ, Gao W, White HD, Eikelboom JW.

Am J Cardiovasc Drugs. 2004;4(2):107-15. Review.

PMID:
15049722
[PubMed - indexed for MEDLINE]
8.

Enoxaparin: a review of its use in ST-segment elevation myocardial infarction.

Carter NJ, McCormack PL, Plosker GL.

Drugs. 2008;68(5):691-710. Review.

PMID:
18370449
[PubMed - indexed for MEDLINE]
9.

Enoxaparin. A review of its clinical potential in the management of coronary artery disease.

Noble S, Spencer CM.

Drugs. 1998 Aug;56(2):259-72. Review.

PMID:
9711450
[PubMed - indexed for MEDLINE]
10.

[Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].

Ottani F, Ferrini D, Di Pasquale G, Galvani M.

Ital Heart J Suppl. 2001 Sep;2(9):958-71. Review. Italian.

PMID:
11675833
[PubMed - indexed for MEDLINE]
11.

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.

Arch Intern Med. 2007 Dec 10;167(22):2423-30. Review.

PMID:
18071163
[PubMed - indexed for MEDLINE]
12.

[Low-molecular-weight heparins in acute coronary syndrome: acquired results and new perspectives].

Ugo F, Ardissino D.

G Ital Cardiol (Rome). 2006 Dec;7(12):771-9. Review. Italian.

PMID:
17294602
[PubMed - indexed for MEDLINE]
13.

Adjunctive low molecular weight heparin during fibrinolytic therapy in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.

Singh S, Bahekar A, Molnar J, Khosla S, Arora R.

Clin Cardiol. 2009 Jul;32(7):358-64. doi: 10.1002/clc.20432. Review.

PMID:
19609890
[PubMed - indexed for MEDLINE]
14.

The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.

Mukherjee D, Eagle KA.

Prog Cardiovasc Dis. 2007 Nov-Dec;50(3):167-80. Review.

PMID:
17976502
[PubMed - indexed for MEDLINE]
15.

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes.

Galla JM, Mahaffey KW.

Expert Opin Pharmacother. 2005 Jun;6(7):1241-51. Review.

PMID:
15957976
[PubMed - indexed for MEDLINE]
16.

Enoxaparin for the treatment of acute myocardial infarction with persistent ST-segment elevation.

Rubboli A, Herzfeld I, Maresta A.

Minerva Cardioangiol. 2003 Oct;51(5):463-70, 470-4. Review.

PMID:
14551516
[PubMed - indexed for MEDLINE]
Free Article
17.

Enoxaparin in acute coronary syndromes.

Lee S, Gibson CM.

Expert Rev Cardiovasc Ther. 2007 May;5(3):387-99. Review.

PMID:
17489664
[PubMed - indexed for MEDLINE]
18.

Low molecular weight heparins in the management of unstable angina/non-Q-wave myocardial infarction.

Cohen M.

Semin Thromb Hemost. 1999;25 Suppl 3:113-21. Review.

PMID:
10549726
[PubMed - indexed for MEDLINE]
19.

Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.

Rubboli A, Ottani F, Capecchi A, Brancaleoni R, Galvani M, Swahn E.

Cardiology. 2007;107(2):132-9. Epub 2006 Jul 21. Review.

PMID:
16864962
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis.

Silvain J, Beygui F, Barthélémy O, Pollack C Jr, Cohen M, Zeymer U, Huber K, Goldstein P, Cayla G, Collet JP, Vicaut E, Montalescot G.

BMJ. 2012 Feb 3;344:e553. doi: 10.1136/bmj.e553. Review.

PMID:
22306479
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk